Icon

ICON partners with Boston Clinical Research Institute

Friday, May 13, 2011 11:25 AM

Global CRO ICON, based in Ireland, is widening its access to key opinion leader expertise and clinical investigators, both in the U.S. and worldwide, through an alliance with Boston Clinical Research Institute (BCRI), according to PharmaTimes.

More... »

The CenterWatch Monthly, May 2011

Monday, May 2, 2011 11:05 AM

Sites worldwide rate PPD, Kendle, ICON top CROs

More... »

Harlan names Manuela Leone president, CRS

Wednesday, April 27, 2011 12:01 PM

Global CRO Harlan Laboratories has appointed Dr. Manuela Leone as president of contract research services (CRS) for the company.

More... »

Icon and Acronet sign alliance agreement

Monday, April 25, 2011 12:15 PM

Ireland-based Icon,a global CRO for the pharmaceutical, biotechnology and medical device industries, and Japan-based CRO Acronet, have signed an alliance agreement. The two companies will collaborate to offer global and Japanese pharmaceutical clients a range of clinical development capabilities to manage trials, regionally and globally.

More... »

Chiltern, Icon expand offices

Thursday, March 31, 2011 12:19 PM

Two global CROs, Chiltern International and Icon, have extended their operations in Europe and the Asia Pacific region respectively with new offices in the Netherlands and China, according to PharmaTimes.

More... »

Lexicon Pharmaceuticals names Dr. Pablo Lapuerta CMO

Tuesday, March 29, 2011 12:15 PM

Lexicon Pharmaceuticals has named Pablo Lapuerta, M.D., chief medical officer. He will be responsible for directing clinical development of Lexicon's drug candidates from phase II proof-of-concept through phase III and approval.

More... »

inVentiv Health buys i3 divisions, Campbell Alliance, allowing it to compete with CRO industry’s big players

Monday, January 31, 2011 08:00 AM

Ingenix, a UnitedHealth Group subsidiary that provides health care information to the managed care and drug development sectors, is selling off its clinical trial management and contract research services. Those holdings include i3 Research, i3 Statprobe and i3 Pharma Resourcing. 

More... »

Fortune ranking of fastest-growing companies illustrates the cyclical performance of CRO sector

Tuesday, September 14, 2010 07:53 AM

Fortune’s recent release of its 2010 list of 100 fastest-growing companies illustrates how sectors that perform in cycles, such as CROs, can either benefit or lose out when measured by a snapshot in time.

More... »

ICON Earnings Flat in Q1

Tuesday, April 27, 2010 01:53 PM

Dublin -based contract research organization ICON reported first quarter net revenues of $219 million, down slightly from $219.8 million in the same period last year.  Income from operations was $22.2 million, or $0.37 per share on a diluted basis, compared with $20.9 million, or $0.35 per share last year.

More... »

ICON Opens Office in Philippines

Tuesday, April 6, 2010 06:59 AM

Dublin, Ireland-based contract research organization (CRO) ICON opened an office in Manila, Philippines, to support the company’s growth in Asia-Pacific.

More... »